Manuscripts
Showing 1556 manuscripts.
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study
Citation
Heather Ribaudo, David W. Haas, Camlin Tierney, Richard B. Kim, Grant R Wilkinson, Roy (Trip) Gulick, David B. Clifford, Catia Marzolini, Courtney V. Fletcher, Karen T. Tashima, Daniel R. Kuritzkes, Edward P. Acosta. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study. Clinical Infectious Diseases. 2006. 42: 401-7.Year
2006
Journal
Clinical Infectious Diseases
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission
Citation
A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006. 20: 1313-21. PMID: 16816561Year
2006
Journal
AIDS
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi
Citation
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi. Sexually Transmitted Diseases. 2006. 33: 604-9. PMID: 16601659Year
2006
Journal
Sexually Transmitted Diseases
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission
Citation
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006. 20: 217-22. PMID: 16511414Year
2006
Journal
AIDS
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.
Citation
HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.. American Journal of Obstetrics and Gynecology. 2006. 195: 1065-74. PMID: 16875654Year
2006
Journal
American Journal of Obstetrics and Gynecology
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Citation
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.. American Journal of Obstetrics and Gynecology. 2006. 42: 610-3. PMID: 16773030Year
2006
Journal
American Journal of Obstetrics and Gynecology
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
Citation
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.. Journal of Acquired Immune Deficiency Syndromes. 2006. 42: 518-521. PMID: 16810119Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Sensitivity of the ViroSeqTM HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D
Citation
Sensitivity of the ViroSeqTM HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. 2006. 8: 430-2. PMID: 16931582Year
2006
Indinavir impairs endothelial function in healthy HIV-negative men
Citation
Sudha S. Shankar, Michael P. Dube, J. Christopher Gorski, James E. Klaunig, Helmut O. Steinberg. Indinavir impairs endothelial function in healthy HIV-negative men. American Heart Journal. 2005. 150: 933.Year
2005
Journal
American Heart Journal
S phase lymphocytes in HIV disease have a central memory phenotype and rarely have evidence for recent T cell receptor engagement
Citation
Scott F. Sieg, Benigno Rodriguez, Robert Asaad, Wei Jiang, Douglas A. Bazdar, Michael M. Lederman. S phase lymphocytes in HIV disease have a central memory phenotype and rarely have evidence for recent T cell receptor engagement. Journal of Infectious Diseases. 2005. 192: 67-70.Year
2005
Journal
Journal of Infectious Diseases